Gregory M. Sleet, Delaware

Sections

News (100)

1. May 7, 2013 CoreValve Asks High Court To Define Patent Enablement
2. May 3, 2013 Facebook, Mitel Patent Fight Transferred To Calif.
3. April 25, 2013 Edwards Says Heart Valve IP Still Infringed After $74M Verdict
4. April 4, 2013 Celgene's $5.5M Patent Buy Ends Cancer-Therapy IP Row
5. April 2, 2013 Rising Star: Quinn Emanuel's Sean Pak
6. April 1, 2013 Cephalon Beats Challenge To Narcolepsy Drug Patent
7. January 28, 2013 Pfizer Sues Wockhardt To Block Lyrica Generic
8. January 24, 2013 Woodbolt's Patent Challenge Tossed In Diet Supplement Case
9. December 10, 2012 Generics Cos. Ask Fed. Circ. To Nix Pfizer's Lyrica Patent
10. November 28, 2012 Fed. Circ. Won't Rethink Alimta Double Patenting Decision
11. November 13, 2012 Fed. Circ. Affirms $74M Edwards Award In Catheter IP Row
12. October 19, 2012 How They Won It: Kaye, Weil Stand Fast In TV Patent Row
13. October 15, 2012 Allergan's Sanctura IP Appeal Turned Away By High Court
14. September 10, 2012 Tribune Creditors Can't Appeal $1.5B Bond Order: 3rd Circ.
15. August 28, 2012 Tribune Creditors Lose Bid To Nix $1.5B Bond
16. August 24, 2012 Method Patent, Lilly Drug Patent Can Coexist, Fed. Circ. Rules
17. August 23, 2012 Actavis Sued Over Generic Oleptro Plans
18. August 15, 2012 Santarus Seeks To Block Dr. Reddy's Generic Zegerid
19. July 19, 2012 Judge Rules Pfizer's Lyrica Patents Are Valid
20. July 18, 2012 Cephalon Defends Narcolepsy Drug From Generics At Trial